trump and glp 1 GLP-1 price reduction: President announces deal to reduce costs The “Fauxzempic” Crisis: Counterfeit Innovation

This is a year-over-year improvement of 30 percentage points, almost doubling after three years

Orforglipron (Fundayo) is the first oral GLP-1 pill for weight loss with no food or water restrictio

If proven effective in clinical trials, this approach could improve convenience, treatment adherence, and possibly even tolerability for many patients

Bamadutide improves post-meal blood glucose control by significantly enhancing -cell function and slowing down the rate of glucose absorption in the body

Ive recently had an increasing number of patients report dizziness while taking Wegovy (semaglutide)

Novo Nordisks Xultophy gets positive recommendation in Europe, full approval to hopefully come soon!